These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4768085)

  • 1. Plasma levels of estrogens during long-term treatment with depo-medroxyprogesterone acetate as a contraceptive agent.
    Jeppsson S; Johansson ED; Sjörberg NO
    Contraception; 1973 Aug; 8(2):165-70. PubMed ID: 4768085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial histology and circulating levels of medroxyprogesterone acetate (MPA), estradiol, FSH and LH in women with MPA induced amenorrhoea compared with women with secondary amenorrhoea.
    Jeppsson S; Johansson ED; Ljungberg O; Sjöberg NO
    Acta Obstet Gynecol Scand; 1977; 56(1):43-8. PubMed ID: 842303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogenic activity in women receiving an injectable progestogen for contraception.
    Mishell DR; Kharma KM; Thorneycroft IH; Nakamura RM
    Am J Obstet Gynecol; 1972 Jun; 113(3):372-6. PubMed ID: 4637029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administration.
    Hiroi M; Stanczyk FZ; Goebelsmann U; Brenner PF; Lumkin ME; Mishell DR
    Steroids; 1975 Sep; 26(3):373-86. PubMed ID: 1198624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent.
    Jeppsson S; Gershagen S; Johansson ED; Rannevik G
    Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study of different doses of Depo Provera.
    Fotherby K; Koetsawang S; Mathrubutham M
    Contraception; 1980 Nov; 22(5):527-36. PubMed ID: 6451351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Concentration of estrone, estradiol and estriol in the blood of pregnant sheep after induction of estrus with chlormadinone acetate and medroxyprogesterone acetate].
    Halagan J; Arendarcik J
    Vet Med (Praha); 1976 Sep; 21(9):551-6. PubMed ID: 66795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay for serum medroxyprogesterone acetate in Thai women receiving injectable DMPA contraceptive.
    Werawatgoompa S; Pongpradit T; Leepipatpaiboon S; Sukanthanak A
    Contraception; 1979 Oct; 20(4):319-27. PubMed ID: 509958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassays of ethinyl-norgestrienone (R-2323) and medroxyprogesterone acetate (MPA) and their clinical applicability.
    Frick J; Bartsch G; Jakse G
    Urol Res; 1977; 5(2):55-9. PubMed ID: 69351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA.
    Ortiz A; Hirol M; Stanczyk FZ; Goebelsmann U; Mishell DR
    J Clin Endocrinol Metab; 1977 Jan; 44(1):32-8. PubMed ID: 833262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I; Khan AR; Jahan FA
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained effects on synthetic ovarian steroids of rat myometrial contractility.
    Parkington HC; Lipton A
    J Endocrinol; 1976 Aug; 70(2):223-7. PubMed ID: 965882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of depot-medroxyprogesterone acetate on lipoprotein metabolism.
    Garza-Flores J; De la Cruz DL; Valles de Bourges V; Sanchez-Nuncio R; Martinez M; Fuziwara JL; Pérez-Palacios G
    Contraception; 1991 Jul; 44(1):61-71. PubMed ID: 1832626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of medroxyprogesterone acetate (MPA), estradiol and progesterone in the rhesus monkey after intramuscular adminstration of Depo-Provera.
    Mora G; Johansson ED
    Contraception; 1976 Sep; 14(3):343-50. PubMed ID: 824097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of contraceptive seroids in breast milk and plasma of lactating women.
    Saxena BN; Shrimanker K; Grudzinskas JG
    Contraception; 1977 Dec; 16(6):605-13. PubMed ID: 606500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma medroxyprogesterone acetate levels following intramuscular or oral administration in patients with endometrial adenocarcinoma.
    Laatikainen T; Nieminen U; Adlercreutz H
    Acta Obstet Gynecol Scand; 1979; 58(1):95-9. PubMed ID: 419965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of injectable contraceptives in Assiut, Egypt.
    Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
    Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.